Statin use is associated with lower risk of PTEN-null and lethal prostate cancer

Emma H. Allott, Ericka M. Ebot, Konrad H. Stopsack, Amparo G. Gonzalez-Feliciano, Sarah C. Markt, Kathryn M. Wilson, Thomas U. Ahearn, Travis A. Gerke, Mary K. Downer, Jennifer R. Rider, Stephen J. Freedland, Tamara L. Lotan, Philip W. Kantoff, Elizabeth A. Platz, Massimo Loda, Meir J. Stampfer, Edward Giovannucci, Christopher J. Sweeney, Stephen P. Finn, Lorelei A. Mucci

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Statin use is associated with lower risk of PTEN-null and lethal prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences